Igor Vujic

2.4k citations

50 papers · 1.4k indexed · h-index 22

Impact in

Dermatology top 2%
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Colorectal Cancer Treatments and Studies

Papers in ⓘ

Dermatology 12
- Dermatology and Skin Diseases 5
Periodontics 4

Co-authors: Martina Sanlorenzo (32 shared papers)Klemens Rappersberger (35 shared papers)Susana Ortiz‐Urda (23 shared papers)Christian Posch (29 shared papers)Pietro Quaglino (10 shared papers)Adil Daud (5 shared papers)Alain P. Algazi (4 shared papers)Babak Itzinger-Monshi (18 shared papers)
Journals: JDDG Journal der Deutschen Dermatologischen Gesellschaft (6 papers)Journal of Investigative Dermatology (5 papers)Journal of the American Academy of Dermatology (4 papers)Journal of the European Academy of Dermatology and Venereology (4 papers)Oncotarget (4 papers)
Partner nations: Austria United States Italy

In The Last Decade

Igor Vujic

50 papers receiving 1.4k citations

Peers

Countries citing papers authored by Igor Vujic

Since Specialization

Citations

This map shows the geographic impact of Igor Vujic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Vujic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Vujic more than expected).

Fields of papers citing papers by Igor Vujic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Vujic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Vujic. The network helps show where Igor Vujic may publish in the future.

Co-authors

The 25 scholars most cited alongside Igor Vujic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Igor Vujic Line = papers co-authored together Igor Vujic links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression JAMA Dermatology ·Martina Sanlorenzo, Igor Vujic, Adil Daud, Alain P. Algazi, Matthew A. Gubens, Sara Alcántara Luna, Kevin Lin, Pietro Quaglino, Klemens Rappersberger, Susana Ortiz‐Urda	2015	358
2	DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics Nanoscale ·Alfonso Latorre, Christian Posch, Yolanda Garcimartín, Anna Celli, Martina Sanlorenzo, Igor Vujic, Jeffrey Ma, Mitchell Zekhtser, Klemens Rappersberger, Susana Ortiz‐Urda, Álvaro Somoza	2014	70
3	The Risk of Melanoma in Airline Pilots and Cabin Crew JAMA Dermatology ·Martina Sanlorenzo, Mackenzie R. Wehner, Eleni Linos, John Kornak, Wolfgang Kainz, Christian Posch, Igor Vujic, Katia Johnston, Deborah Gho, Gabriela Monico, James T. McGrath, Simona Osella‐Abate, Pietro Quaglino, James E. Cleaver, Susana Ortiz‐Urda	2014	70
4	Melanoma immunotherapy Cancer Biology & Therapy ·Martina Sanlorenzo, Igor Vujic, Christian Posch, Akshay Dajee, Adam Yen, Sarasa T. Kim, Michelle T. Ashworth, Michael D. Rosenblum, Alain P. Algazi, Simona Osella‐Abate, Pietro Quaglino, Adil Daud, Susanna Ortiz-Urda	2014	67
5	Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma Journal of the American Academy of Dermatology ·Martina Sanlorenzo, Aditi Choudhry, Igor Vujic, Christian Posch, Chong Ae Kim, Katia Johnston, Melissa M. Meier, Simona Osella‐Abate, Pietro Quaglino, Adil Daud, Alain P. Algazi, Klemens Rappersberger, Susana Ortiz‐Urda	2014	58
6	Metformin and trametinib have synergistic effects on cell viability and tumor growth inNRASmutant cancer Oncotarget ·Igor Vujic, Martina Sanlorenzo, Christian Posch, Rosaura Esteve‐Puig, Adam Yen, Andrew Kwong, Aaron Tsumura, Ryan M. Murphy, Klemens Rappersberger, Susana Ortiz‐Urda	2014	55
7	Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma Journal of Investigative Dermatology ·Christian Posch, Brian D. Cholewa, Igor Vujic, Martina Sanlorenzo, Jeffrey Ma, Sarasa T. Kim, Sonja Kleffel, Tobias Schatton, Klemens Rappersberger, Rosie Elizabeth Ann Gutteridge, Nihal Ahmad, Susana Ortiz‐Urda	2015	54
8	The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients Journal of the American Academy of Dermatology ·Christian Posch, Babak Itzinger-Monshi, Tamara Quint, Igor Vujic, Nikolaus Lilgenau, Klemens Rappersberger	2017	49
9	Apremilast in psoriasis – a prospective real‐world study Journal of the European Academy of Dermatology and Venereology ·Igor Vujic, Robert Herman, Martina Sanlorenzo, Christian Posch, Babak Itzinger-Monshi, Klemens Rappersberger, Leo Richter	2017	46
10	Efficacy of intravenous immunoglobulins in livedoid vasculopathy: Long-term follow-up of 11 patients Journal of the American Academy of Dermatology ·Babak Itzinger-Monshi, Christian Posch, Igor Vujic, Alma Sesti, S Sobótka, Klemens Rappersberger	2014	43
11	Mycoplasma pneumoniae‐associated mucositis – case report and systematic review of literature Journal of the European Academy of Dermatology and Venereology ·Igor Vujic, Arun Shroff, Michalina Grzelka, Christian Posch, Babak Itzinger-Monshi, Martina Sanlorenzo, Susana Ortiz‐Urda, Klemens Rappersberger	2014	34
12	Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma PLoS ONE ·Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn	2014	33
13	The burden of malignant melanoma – Lessons to be learned from Austria European Journal of Cancer ·Babak Itzinger-Monshi, Marin Vujic, Danijel Kivaranovic, Alma Sesti, Willi Oberaigner, Igor Vujic, Susana Ortiz‐Urda, Christian Posch, Hans G. Feichtinger, Monika Hackl, Klemens Rappersberger	2016	31
14	Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells Oncotarget ·Igor Vujic, Martina Sanlorenzo, Rosaura Esteve‐Puig, Marin Vujic, Andrew Kwong, Aaron Tsumura, Ryan M. Murphy, Adrian Moy, Christian Posch, Babak Itzinger-Monshi, Klemens Rappersberger, Susana Ortiz‐Urda	2016	31
15	BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody Clinical Cancer Research ·Martina Sanlorenzo, Igor Vujic, Arianna Floris, Mauro Novelli, Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, Valeria Leuci, Ramona Rotolo, Chiara Donini, Marco Basiricò, Pietro Quaglino, Maria Teresa Fierro, Silvia Giordano, Maria Sibilia, Fabrizio Carnevale‐Schianca, Massimo Aglietta, Dario Sangiolo	2018	30
16	Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy Science Translational Medicine ·Jörg Klufa, Thomas Bauer, Buck Hanson, Craig W. Herbold, Philipp Starkl, Beate M. Lichtenberger, Dagmar Šrůtková, Daniel Schulz, Igor Vujic, Thomas Mohr, Klemens Rappersberger, Bernd Bodenmiller, Hana Kozáková, Sylvia Knapp, Alexander Loy, Maria Sibilia	2019	28
17	The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis Journal of the American Academy of Dermatology ·Paolo Dapavo, Igor Vujic, Maria Teresa Fierro, Pietro Quaglino, Martina Sanlorenzo	2016	28
18	The Risk of Melanoma in Pilots and Cabin Crew JAMA Dermatology ·Martina Sanlorenzo, Igor Vujic, Christian Posch, James E. Cleaver, Pietro Quaglino, Susana Ortiz‐Urda	2014	24
19	Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles Biomedical Microdevices ·Christian Posch, Alfonso Latorre, Michelle B. Crosby, Anna Celli, Ana Latorre, Igor Vujic, Martina Sanlorenzo, Gary A. Green, Jingly F. Weier, Mitchell Zekhtser, Jeffrey Ma, Gabriela Monico, Devron H. Char, Denis Jusufbegovic, Klemens Rappersberger, Álvaro Somoza, Susana Ortiz‐Urda	2015	23
20	Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients British Journal of Cancer ·Christian Posch, Felix Weihsengruber, Kristina Bartsch, Valentin Feichtenschlager, Martina Sanlorenzo, Igor Vujic, Babak Itzinger-Monshi, Susana Ortiz‐Urda, Klemens Rappersberger	2014	23

About Igor Vujic

Igor Vujic is a scholar working on Dermatology, Periodontics, Immunology, Oncology and Immunology and Allergy, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (10 papers), Cutaneous Melanoma Detection and Management (9 papers), Psoriasis: Treatment and Pathogenesis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (6 papers), Dermatology and Skin Diseases (5 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Dermatology (227 citations), Oncology (691 citations), Immunology (338 citations), Molecular Biology (488 citations) and Cancer Research (102 citations). Igor Vujic has collaborated with scholars based in Austria, United States and Italy. Frequent co-authors include Martina Sanlorenzo, Klemens Rappersberger, Susana Ortiz‐Urda, Christian Posch, Pietro Quaglino, Adil Daud, Alain P. Algazi, Babak Itzinger-Monshi, Kevin Lin and Sara Alcántara Luna. Their work appears in journals such as JDDG Journal der Deutschen Dermatologischen Gesellschaft, Journal of Investigative Dermatology, Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact